A citation-based method for searching scientific literature

Sofia Esteves, Sara Duarte-Silva, Patrícia Maciel. Med Res Rev 2017
Times Cited: 12







List of co-cited articles
102 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Spinocerebellar ataxias: prospects and challenges for therapy development.
Tetsuo Ashizawa, Gülin Öz, Henry L Paulson. Nat Rev Neurol 2018
72
58

Polyglutamine spinocerebellar ataxias - from genes to potential treatments.
Henry L Paulson, Vikram G Shakkottai, H Brent Clark, Harry T Orr. Nat Rev Neurosci 2017
129
50

Genetics, Mechanisms, and Therapeutic Progress in Polyglutamine Spinocerebellar Ataxias.
Ronald A M Buijsen, Lodewijk J A Toonen, Sarah L Gardiner, Willeke M C van Roon-Mom. Neurotherapeutics 2019
38
41

CRISPR/Cas9-Targeted Deletion of Polyglutamine in Spinocerebellar Ataxia Type 3-Derived Induced Pluripotent Stem Cells.
Shuming Ouyang, Yingjun Xie, Zeyu Xiong, Yi Yang, Yexing Xian, Zhanhui Ou, Bing Song, Yuchang Chen, Yuhuan Xie, Haoxian Li,[...]. Stem Cells Dev 2018
28
33


CRISPR/Cas9 Editing of the Mutant Huntingtin Allele In Vitro and In Vivo.
Alex Mas Monteys, Shauna A Ebanks, Megan S Keiser, Beverly L Davidson. Mol Ther 2017
134
25


Permanent inactivation of Huntington's disease mutation by personalized allele-specific CRISPR/Cas9.
Jun Wan Shin, Kyung-Hee Kim, Michael J Chao, Ranjit S Atwal, Tammy Gillis, Marcy E MacDonald, James F Gusella, Jong-Min Lee. Hum Mol Genet 2016
118
25


The Truncated C-terminal Fragment of Mutant ATXN3 Disrupts Mitochondria Dynamics in Spinocerebellar Ataxia Type 3 Models.
Jung-Yu Hsu, Yu-Ling Jhang, Pei-Hsun Cheng, Yu-Fan Chang, Su-Han Mao, Han-In Yang, Chia-Wei Lin, Chuan-Mu Chen, Shang-Hsun Yang. Front Mol Neurosci 2017
17
25

Polyglutamine tracts regulate beclin 1-dependent autophagy.
Avraham Ashkenazi, Carla F Bento, Thomas Ricketts, Mariella Vicinanza, Farah Siddiqi, Mariana Pavel, Ferdinando Squitieri, Maarten C Hardenberg, Sara Imarisio, Fiona M Menzies,[...]. Nature 2017
170
25

Polyglutamine (PolyQ) diseases: genetics to treatments.
Hueng-Chuen Fan, Li-Ing Ho, Ching-Shiang Chi, Shyi-Jou Chen, Giia-Sheun Peng, Tzu-Min Chan, Shinn-Zong Lin, Horng-Jyh Harn. Cell Transplant 2014
87
25

Excitation-induced ataxin-3 aggregation in neurons from patients with Machado-Joseph disease.
Philipp Koch, Peter Breuer, Michael Peitz, Johannes Jungverdorben, Jaideep Kesavan, Daniel Poppe, Jonas Doerr, Julia Ladewig, Jerome Mertens, Thomas Tüting,[...]. Nature 2011
224
25

Allele-specific RNA silencing of mutant ataxin-3 mediates neuroprotection in a rat model of Machado-Joseph disease.
Sandro Alves, Isabel Nascimento-Ferreira, Gwennaëlle Auregan, Raymonde Hassig, Noëlle Dufour, Emmanuel Brouillet, Maria C Pedroso de Lima, Philippe Hantraye, Luís Pereira de Almeida, Nicole Déglon. PLoS One 2008
106
25

Aberrant Autophagic Response in The Muscle of A Knock-in Mouse Model of Spinal and Bulbar Muscular Atrophy.
Paola Rusmini, Maria Josefa Polanco, Riccardo Cristofani, Maria Elena Cicardi, Marco Meroni, Mariarita Galbiati, Margherita Piccolella, Elio Messi, Elisa Giorgetti, Andrew P Lieberman,[...]. Sci Rep 2015
37
16

Ataxin-3 suppresses polyglutamine neurodegeneration in Drosophila by a ubiquitin-associated mechanism.
John M Warrick, Lance M Morabito, Julide Bilen, Beth Gordesky-Gold, Lynn Z Faust, Henry L Paulson, Nancy M Bonini. Mol Cell 2005
197
16


CHIP overexpression reduces mutant androgen receptor protein and ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model.
Hiroaki Adachi, Masahiro Waza, Keisuke Tokui, Masahisa Katsuno, Makoto Minamiyama, Fumiaki Tanaka, Manabu Doyu, Gen Sobue. J Neurosci 2007
111
16

Enhancement of proteasome activity by a small-molecule inhibitor of USP14.
Byung-Hoon Lee, Min Jae Lee, Soyeon Park, Dong-Chan Oh, Suzanne Elsasser, Ping-Chung Chen, Carlos Gartner, Nevena Dimova, John Hanna, Steven P Gygi,[...]. Nature 2010
629
16

Polyglutamine expansion, protein aggregation, proteasome activity, and neural survival.
Qunxing Ding, Jennifer J Lewis, Kenneth M Strum, Edgardo Dimayuga, Annadora J Bruce-Keller, Jay C Dunn, Jeffrey N Keller. J Biol Chem 2002
90
16


Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia.
Han-Xiang Deng, Wenjie Chen, Seong-Tshool Hong, Kym M Boycott, George H Gorrie, Nailah Siddique, Yi Yang, Faisal Fecto, Yong Shi, Hong Zhai,[...]. Nature 2011
756
16

Targeting Hsp90/Hsp70-based protein quality control for treatment of adult onset neurodegenerative diseases.
William B Pratt, Jason E Gestwicki, Yoichi Osawa, Andrew P Lieberman. Annu Rev Pharmacol Toxicol 2015
137
16

PolyQ proteins interfere with nuclear degradation of cytosolic proteins by sequestering the Sis1p chaperone.
Sae-Hun Park, Yury Kukushkin, Rajat Gupta, Taotao Chen, Ayano Konagai, Mark S Hipp, Manajit Hayer-Hartl, F Ulrich Hartl. Cell 2013
224
16

CHIP suppresses polyglutamine aggregation and toxicity in vitro and in vivo.
Victor M Miller, Rick F Nelson, Cynthia M Gouvion, Aislinn Williams, Edgardo Rodriguez-Lebron, Scott Q Harper, Beverly L Davidson, Michael R Rebagliati, Henry L Paulson. J Neurosci 2005
170
16

Activation of Hsp70 reduces neurotoxicity by promoting polyglutamine protein degradation.
Adrienne M Wang, Yoshinari Miyata, Susan Klinedinst, Hwei-Ming Peng, Jason P Chua, Tomoko Komiyama, Xiaokai Li, Yoshihiro Morishima, Diane E Merry, William B Pratt,[...]. Nat Chem Biol 2013
123
16

Chronic treatment with 17-DMAG improves balance and coordination in a new mouse model of Machado-Joseph disease.
Anabela Silva-Fernandes, Sara Duarte-Silva, Andreia Neves-Carvalho, Marina Amorim, Carina Soares-Cunha, Pedro Oliveira, Kenneth Thirstrup, Andreia Teixeira-Castro, Patrícia Maciel. Neurotherapeutics 2014
63
16

Global changes to the ubiquitin system in Huntington's disease.
Eric J Bennett, Thomas A Shaler, Ben Woodman, Kwon-Yul Ryu, Tatiana S Zaitseva, Christopher H Becker, Gillian P Bates, Howard Schulman, Ron R Kopito. Nature 2007
383
16

Modulation of Molecular Chaperones in Huntington's Disease and Other Polyglutamine Disorders.
Sara D Reis, Brígida R Pinho, Jorge M A Oliveira. Mol Neurobiol 2017
20
16

Inhibition of hsp70 by methylene blue affects signaling protein function and ubiquitination and modulates polyglutamine protein degradation.
Adrienne M Wang, Yoshihiro Morishima, Kelly M Clapp, Hwei-Ming Peng, William B Pratt, Jason E Gestwicki, Yoichi Osawa, Andrew P Lieberman. J Biol Chem 2010
66
16

CHIP deletion reveals functional redundancy of E3 ligases in promoting degradation of both signaling proteins and expanded glutamine proteins.
Yoshihiro Morishima, Adrienne M Wang, Zhigang Yu, William B Pratt, Yoichi Osawa, Andrew P Lieberman. Hum Mol Genet 2008
88
16

A model in which heat shock protein 90 targets protein-folding clefts: rationale for a new approach to neuroprotective treatment of protein folding diseases.
William B Pratt, Yoshihiro Morishima, Jason E Gestwicki, Andrew P Lieberman, Yoichi Osawa. Exp Biol Med (Maywood) 2014
15
16

Inhibiting the ubiquitin-proteasome system leads to preferential accumulation of toxic N-terminal mutant huntingtin fragments.
Xiang Li, Chuan-En Wang, Shanshan Huang, Xingshun Xu, Xiao-Jiang Li, He Li, Shihua Li. Hum Mol Genet 2010
60
16



Altered transcriptional regulation in cells expressing the expanded polyglutamine androgen receptor.
Andrew P Lieberman, George Harmison, Andrew D Strand, James M Olson, Kenneth H Fischbeck. Hum Mol Genet 2002
107
16


UBQLN2 Mediates Autophagy-Independent Protein Aggregate Clearance by the Proteasome.
Roland Hjerpe, John S Bett, Matthew J Keuss, Alexandra Solovyova, Thomas G McWilliams, Clare Johnson, Indrajit Sahu, Joby Varghese, Nicola Wood, Melanie Wightman,[...]. Cell 2016
155
16

Co-chaperone CHIP associates with expanded polyglutamine protein and promotes their degradation by proteasomes.
Nihar Ranjan Jana, Priyanka Dikshit, Anand Goswami, Svetlana Kotliarova, Shigeo Murata, Keiji Tanaka, Nobuyuki Nukina. J Biol Chem 2005
230
16

Heat shock protein 70 chaperone overexpression ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model by reducing nuclear-localized mutant androgen receptor protein.
Hiroaki Adachi, Masahisa Katsuno, Makoto Minamiyama, Chen Sang, Gerassimos Pagoulatos, Charalampos Angelidis, Moriaki Kusakabe, Atsushi Yoshiki, Yasushi Kobayashi, Manabu Doyu,[...]. J Neurosci 2003
187
16

Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity.
F Ann Ran, Patrick D Hsu, Chie-Yu Lin, Jonathan S Gootenberg, Silvana Konermann, Alexandro E Trevino, David A Scott, Azusa Inoue, Shogo Matoba, Yi Zhang,[...]. Cell 2013
16

Allele-specific silencing of mutant huntingtin and ataxin-3 genes by targeting expanded CAG repeats in mRNAs.
Jiaxin Hu, Masayuki Matsui, Keith T Gagnon, Jacob C Schwartz, Sylvie Gabillet, Khalil Arar, Jun Wu, Ilya Bezprozvanny, David R Corey. Nat Biotechnol 2009
171
16

The Self-Inactivating KamiCas9 System for the Editing of CNS Disease Genes.
Nicolas Merienne, Gabriel Vachey, Lucie de Longprez, Cécile Meunier, Virginie Zimmer, Guillaume Perriard, Mathieu Canales, Amandine Mathias, Lucas Herrgott, Tim Beltraminelli,[...]. Cell Rep 2017
50
16

An evaluation of oligonucleotide-based therapeutic strategies for polyQ diseases.
Agnieszka Fiszer, Marta Olejniczak, Pawel M Switonski, Joanna P Wroblewska, Joanna Wisniewska-Kruk, Agnieszka Mykowska, Wlodzimierz J Krzyzosiak. BMC Mol Biol 2012
26
16

Genetic correction of Huntington's disease phenotypes in induced pluripotent stem cells.
Mahru C An, Ningzhe Zhang, Gary Scott, Daniel Montoro, Tobias Wittkop, Sean Mooney, Simon Melov, Lisa M Ellerby. Cell Stem Cell 2012
229
16

The Biology of Huntingtin.
Frédéric Saudou, Sandrine Humbert. Neuron 2016
328
16

Huntington disease.
Gillian P Bates, Ray Dorsey, James F Gusella, Michael R Hayden, Chris Kay, Blair R Leavitt, Martha Nance, Christopher A Ross, Rachael I Scahill, Ronald Wetzel,[...]. Nat Rev Dis Primers 2015
522
16

Self-duplexing CUG repeats selectively inhibit mutant huntingtin expression.
Agnieszka Fiszer, Marta Olejniczak, Paulina Galka-Marciniak, Agnieszka Mykowska, Wlodzimierz J Krzyzosiak. Nucleic Acids Res 2013
23
16

RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model.
Scott Q Harper, Patrick D Staber, Xiaohua He, Steven L Eliason, Inês H Martins, Qinwen Mao, Linda Yang, Robert M Kotin, Henry L Paulson, Beverly L Davidson. Proc Natl Acad Sci U S A 2005
488
16

Therapies targeting DNA and RNA in Huntington's disease.
Edward J Wild, Sarah J Tabrizi. Lancet Neurol 2017
121
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.